Single cell sequencing reveals heterogeneity within ovarian cancer epithelium and cancer associated stromal cells.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 28111004)

Published in Gynecol Oncol on January 19, 2017

Authors

Boris J Winterhoff1, Makayla Maile1, Amit Kumar Mitra2, Attila Sebe3, Martina Bazzaro1, Melissa A Geller1, Juan E Abrahante4, Molly Klein5, Raffaele Hellweg6, Sally A Mullany6, Kenneth Beckman7, Jerry Daniel7, Timothy K Starr8

Author Affiliations

1: Department of Obstetrics, Gynecology & Women's Health, University of Minnesota, Minneapolis, MN, USA; Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA.
2: Department of Genetics, Cell Biology & Development, University of Minnesota, Minneapolis, MN, USA.
3: Division of Medical Biotechnology, Paul Ehrlich Institute, Langen, Germany.
4: University of Minnesota Informatics Institute, University of Minnesota, Minneapolis, MN, USA.
5: Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN, USA.
6: Department of Obstetrics, Gynecology & Women's Health, University of Minnesota, Minneapolis, MN, USA.
7: Genomics Center, University of Minnesota, Minneapolis, MN, USA.
8: Department of Obstetrics, Gynecology & Women's Health, University of Minnesota, Minneapolis, MN, USA; Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA. Electronic address: star0044@umn.edu.

Articles cited by this

Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol (2009) 235.12

Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A (2005) 167.46

TreeView: an application to display phylogenetic trees on personal computers. Comput Appl Biosci (1996) 56.57

PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet (2003) 53.59

Integrated genomic analyses of ovarian carcinoma. Nature (2011) 47.72

RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome. BMC Bioinformatics (2011) 25.76

Open source clustering software. Bioinformatics (2004) 23.17

Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits. Nat Rev Cancer (2009) 18.53

Identification of genes periodically expressed in the human cell cycle and their expression in tumors. Mol Biol Cell (2002) 17.32

Efficient tumour formation by single human melanoma cells. Nature (2008) 16.35

Molecular mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell Biol (2014) 10.04

The biology of ovarian cancer: new opportunities for translation. Nat Rev Cancer (2009) 9.01

Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome. Clin Cancer Res (2008) 8.17

Molecular signatures database (MSigDB) 3.0. Bioinformatics (2011) 8.08

Identification and characterization of ovarian cancer-initiating cells from primary human tumors. Cancer Res (2008) 6.38

Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma. Science (2014) 6.09

Prognostically relevant gene signatures of high-grade serous ovarian carcinoma. J Clin Invest (2012) 3.64

Molecular phenotyping of human ovarian cancer stem cells unravels the mechanisms for repair and chemoresistance. Cell Cycle (2009) 3.60

Whole-genome characterization of chemoresistant ovarian cancer. Nature (2015) 3.06

Human housekeeping genes, revisited. Trends Genet (2013) 2.95

Inferring tumour purity and stromal and immune cell admixture from expression data. Nat Commun (2013) 2.94

CD133 expression defines a tumor initiating cell population in primary human ovarian cancer. Stem Cells (2009) 2.76

Stromal gene expression defines poor-prognosis subtypes in colorectal cancer. Nat Genet (2015) 2.76

Stromal contribution to the colorectal cancer transcriptome. Nat Genet (2015) 2.59

Aldehyde dehydrogenase in combination with CD133 defines angiogenic ovarian cancer stem cells that portend poor patient survival. Cancer Res (2011) 2.50

Targeting aldehyde dehydrogenase cancer stem cells in ovarian cancer. Mol Cancer Ther (2010) 2.27

Expression of aldehyde dehydrogenase and CD133 defines ovarian cancer stem cells. Int J Cancer (2011) 2.05

Prognostic and therapeutic relevance of molecular subtypes in high-grade serous ovarian cancer. J Natl Cancer Inst (2014) 1.93

Epithelial-Mesenchymal Plasticity: A Central Regulator of Cancer Progression. Trends Cell Biol (2015) 1.87

Overexpression of epithelial cell adhesion molecule in primary, metastatic, and recurrent/chemotherapy-resistant epithelial ovarian cancer: implications for epithelial cell adhesion molecule-specific immunotherapy. Int J Gynecol Cancer (2009) 1.38

Ovarian cancer stem cell markers: prognostic and therapeutic implications. Cancer Lett (2012) 1.38

Prevalence of epithelial ovarian cancer stem cells correlates with recurrence in early-stage ovarian cancer. J Oncol (2011) 1.15

Ovarian cancer stem cells: are they real and why are they important? Gynecol Oncol (2013) 1.04

Gene expression and pathway analysis of ovarian cancer cells selected for resistance to cisplatin, paclitaxel, or doxorubicin. J Ovarian Res (2011) 1.04

Analysis of chemotherapy response programs in ovarian cancers by the next-generation sequencing technologies. Gynecol Oncol (2010) 0.88